Multicellular hepatic in vitro models using NANOSTACKS^TM: human-relevant models for drug response prediction.

Authors

Abdullah C Talari, Raffaello Sbordoni, Valmira Hoti, Talha Jalil, Imran I Patel, Francis L Martin, Ahtasham Raza, Valon Llabjani

Published in

In vitro models. Volume 4. Issue 2. Pages 131-144. Epub Jun 18, 2025.

Abstract

Drug-induced liver injury (DILI) continues to be one of the leading causes of drug attrition during clinical trials, as well as the number one cause of post-market drug withdrawal due to the limited predictive accuracy of preclinical animals and conventional in vitro models. In this study, the NANOSTACKS^TM platform was introduced as a novel in vitro tool to build in vivo-relevant organ models for predicting drug responses. In particular, hepatic models, including monocultures of primary human hepatocytes (PHH), tricultures of PHH, human stellate cells (HSC), and human liver endothelial cells (LECs), and tetracultures of PHH, HSC, LECs, and human Kupffer cells (KC) were developed under static and orbital-induced mixing flow conditions. All hepatic models were characterised by assessing albumin, urea, CYP3A4, and ATP production. In addition, the preclinical DILI screening potential of the orbital-induced mixing flow monoculture and triculture models was assessed by testing the hepatotoxicity of zileuton, buspirone, and cyclophosphamide. NANOSTACKS™ represents a promising tool for the development of complex in vitro models.

PMID:
40708813
Bibliographic data and abstract were imported from PubMed on 12 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.